Comparative Clinical Analysis of COVID-19 Waves 2 to 5 in Karachi, Pakistan
Overview
This retrospective study analyzed 3190 hospitalized COVID-19 patients across waves 2 to 5 in Karachi, Pakistan, revealing distinct clinical features and outcomes per wave. Wave 4, driven by the Delta variant, exhibited the highest severity and mortality, while wave 2 had the lowest mortality and highest discharge rates.
Background
COVID-19 has caused multiple waves globally, each with unique clinical presentations influenced by viral variants, host factors, and public health measures. In Pakistan, waves 2 through 5 occurred between October 2020 and March 2022, with different dominant variants including Alpha, Delta, and Omicron. Vaccination efforts began in February 2021, impacting disease severity and outcomes. Understanding wave-specific clinical characteristics aids in optimizing patient management and resource allocation.
Data Highlights
Wave
Number of Patients
Discharge Rate (%)
Mortality Rate (%)
Severe COVID on Admission (%)
Intubation Rate (%)
Septic Shock Rate (%)
Cytokine Release Syndrome (%)
Acute Kidney Injury (%)
Median Age (years)
Comorbidities (%)
Wave 2
Not specified
81
18.9
Not specified
Not specified
Not specified
Not specified
Not specified
Not specified
Not specified
Wave 3
Not specified
Not specified
Not specified
Not specified
Not specified
Not specified
32.7
Not specified
Not specified
Not specified
Wave 4
Not specified
Not specified
42.5
79.4
27.1
24.3
Not specified
Not specified
Not specified
Not specified
Wave 5
Not specified
Not specified
Not specified
22.4 (mild cases)
Not specified
Not specified
Not specified
29.2
68
84.6
Key Findings
Wave 2 had the highest discharge rate (81%) and lowest mortality (18.9%).
Wave 3 showed the highest incidence of cytokine release syndrome (32.7%).
Wave 4, dominated by the Delta variant, had the highest severity with 79.4% severe cases on admission, highest intubation (27.1%), septic shock (24.3%), disease progression (50.8%), and mortality (42.5%).
Wave 5 patients were predominantly elderly (median age 68), had mild COVID (22.4%), high comorbidity prevalence (84.6%), and a high rate of acute kidney injury (29.2%).
Mortality odds in wave 4 were significantly higher compared to wave 2 (OR 3.18; 95% CI 2.6–3.8).
Clinical Implications
Clinicians should anticipate higher severity and mortality during waves dominated by more virulent variants such as Delta (wave 4), necessitating aggressive monitoring and early intervention. The high prevalence of comorbidities and acute kidney injury in elderly patients during wave 5 underscores the need for tailored management strategies in this population. Vaccination and evolving therapeutic options likely contributed to improved outcomes in later waves.
Conclusion
Distinct clinical patterns and outcomes characterized each COVID-19 wave in Karachi, with wave 4 being the deadliest due to the Delta variant. Continuous surveillance and adaptive clinical strategies are essential to mitigate morbidity and mortality in future waves.
References
Ahmad et al. 2022 -- National analysis of COVID-19 waves in Pakistan
Buschner et al. -- Comparison of COVID-19 waves in Bavaria
De Paepe et al. -- Mortality trends across COVID-19 waves in Belgium
Noriali et al. -- Clinical differences in Omicron wave